Search hospitals > Pennsylvania > Pittsburgh
UPMC-Presbyterian Hospital
Claim this profilePittsburgh, Pennsylvania 15213
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
Conducts research for Pulmonary Hypertension
306 reported clinical trials
32 medical researchers
Summary
UPMC-Presbyterian Hospital is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Heart Failure, Pulmonary Hypertension and other specialties. UPMC-Presbyterian Hospital is involved with conducting 306 clinical trials across 487 conditions. There are 32 research doctors associated with this hospital, such as Liza C. Villaruz, Dan P. Zandberg, Pablo Sanchez, MD, and Ibrahim Sultan, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Liza C. VillaruzUniversity of Pittsburgh Cancer Institute (UPCI)5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
37 reported clinical trials
53 drugs studied
Dan P. ZandbergUniversity of Pittsburgh Cancer Institute (UPCI)1 year of reported clinical research
Expert in Cancer
Expert in Squamous Cell Carcinoma
18 reported clinical trials
33 drugs studied
Pablo Sanchez, MDResearch Institute at Nationwide Children's Hospital6 years of reported clinical research
Studies Premature Birth
Studies Premature Infants
12 reported clinical trials
18 drugs studied
Ibrahim Sultan, MDUniversity of Pittsburgh Medical Center2 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
11 reported clinical trials
19 drugs studied
Clinical Trials running at UPMC-Presbyterian Hospital
Non-Small Cell Lung Cancer
Lung Cancer
Ulcerative Colitis
Squamous Cell Carcinoma
Laryngeal Cancer
Pneumonia
Cancer
Stroke
Meningioma
Oropharyngeal Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UPMC-Presbyterian Hospital?
UPMC-Presbyterian Hospital is a medical facility located in Pittsburgh, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Heart Failure, Pulmonary Hypertension and other specialties. UPMC-Presbyterian Hospital is involved with conducting 306 clinical trials across 487 conditions. There are 32 research doctors associated with this hospital, such as Liza C. Villaruz, Dan P. Zandberg, Pablo Sanchez, MD, and Ibrahim Sultan, MD.